2026-06-17 08:00
Strong growth provides the platform for the next commercial phase
2026-03-18 08:00
46% growth with strong momentum in the USA and for Pharma Services Q3 (Nov 2025–Jan 2026) (comparison figures are for the same period 2024/2025) Q1–Q3 (May 2025–Jan2026) (comparison figures are for the same period 2024/2025) Significant events during...
2025-12-18 08:30
Positioned for growth in Pharma Services and in the USA
2025-09-11 08:00
Partnership agreement with Tempus and continued organic growth in the USA
2025-03-13 08:00
Quarterly sales doubled, expanding market potential exponentially
2024-12-12 08:00
Significant events during the second quarter Significant events after the end of the period Webcast:When: 12/12 2024 kl. 15.00 CETWhere: registration via: Biovica Q2 Earnings Call, Thu, Dec 12, 2024 at 3 PM CETBroadcast language: in English CEO’s comments...
2024-09-12 10:25
Significantly increased sales in the USA and much improved cash flow
2024-09-12 08:00
Significantly increased sales in the USA and much improved cash flow
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects